Search - tctmd.com

Displaying 381 - 400 of 891

Sort: Relevancy | Date

Presentation TCT 2013

Case 1: Paravalvular Leak After TAVR

Presenter: Alaide Chieffo

October 31, 2013

Presentation TCT 2013

Case 1: Aggressive Lesion Preparation With Rotational Atherectomy Prior to Scaffolding

Presenter: Robert-Jan van Geuns

October 31, 2013

Presentation TCT 2013

Cardiac Surgeon: More Than Just a Gatekeeper! Ideally, a Surgeon with Interventional Skills

Presenter: Vinayak Bapat

October 31, 2013

Presentation TCT 2013

Any Dedicated Valve Therapist with Hands-on TAVR Experience Can Provide Accurate Risk Assessment!

Presenter: Augusto Pichard

October 31, 2013

Presentation TCT 2013

An Artificial Construct to Appease Surgeons that Will Soon Disappear!

Presenter: Ganesh Manoharan

October 31, 2013

Presentation TCT 2013

Absolutely Required - Now and in the Future!

Presenter: Mathew Williams

October 31, 2013

Presentation TCT 2013

A Surgeon Is the Best Person to Determine Risk Assessment for TAVR!

Presenter: A. Pieter Kappetein

October 31, 2013

Presentation TCT 2013

A Standard Cath Lab Is Adequate for All Transfemoral TAVR Cases!

Presenter: Helene Eltchaninoff

October 31, 2013

Presentation TCT 2013

A "True Hybrid OR" for TAVR Procedures If Properly Designed Will Result in Improved Patient Outcomes!

Presenter: Mathew Williams

October 31, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

Presentation TCT 2013

The Odyssey of TAVR: From Concept to Clinical Reality

Presenter: Alain Cribier

October 30, 2013

Presentation TCT 2013

TAVR Developments

Presenter: Spencer King III

October 30, 2013

Presentation TCT 2013

TAVR Accessory Devices: How Much Clinical Trial Rigor and What Are Appropriate Surrogate Endpoints?

Presenter: Alexandra Lansky

October 30, 2013

Presentation TCT 2013

Session and Participant Introduction

Presenter: Mark de Belder

October 30, 2013

Presentation TCT 2013

Regulatory Approval Models for New TAVR "In Class" Devices: Are We Back to the Days of Device vs. Device RCTs?

Presenter: E. Murat Tuzcu

October 30, 2013

Presentation TCT 2013

Regulatory Approval Models for Iterative (Next Version) TAVR Devices: Do We Need RCTS or OPC-Controlled Registries?

Presenter: Jeffrey Popma

October 30, 2013

Presentation TCT 2013

Multilayer Stent to Treat Type B Aortic Dissection with Splanchnic Compromise

Presenter: Hugo Londero

October 30, 2013

Presentation TCT 2013

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Presenter: Daniel Blackman

October 30, 2013

Presentation TCT 2013

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - Against: The TAVR Data are Only on High-Risk Patients with Limited Follow-Up

Presenter: Charles Davidson

October 30, 2013

Presentation TCT 2013

Motion: All Patients with Multivessel Disease and Impaired Left Ventricular Function Should Undergo Revascularization - Against: Revascularization Should be Reserved for Patient...

Presenter: Rita Redberg

October 30, 2013

Advertisement

Case 1: Paravalvular Leak After TAVR

Case 1: Aggressive Lesion Preparation With Rotational Atherectomy Prior to Scaffolding

Cardiac Surgeon: More Than Just a Gatekeeper! Ideally, a Surgeon with Interventional Skills

Any Dedicated Valve Therapist with Hands-on TAVR Experience Can Provide Accurate Risk Assessment!

An Artificial Construct to Appease Surgeons that Will Soon Disappear!

Absolutely Required - Now and in the Future!

A Surgeon Is the Best Person to Determine Risk Assessment for TAVR!

A Standard Cath Lab Is Adequate for All Transfemoral TAVR Cases!

A "True Hybrid OR" for TAVR Procedures If Properly Designed Will Result in Improved Patient Outcomes!

Two Trials to Assess TAVR in Moderate-Risk Patients

The Odyssey of TAVR: From Concept to Clinical Reality

TAVR Developments

TAVR Accessory Devices: How Much Clinical Trial Rigor and What Are Appropriate Surrogate Endpoints?

Session and Participant Introduction

Regulatory Approval Models for New TAVR "In Class" Devices: Are We Back to the Days of Device vs. Device RCTs?

Regulatory Approval Models for Iterative (Next Version) TAVR Devices: Do We Need RCTS or OPC-Controlled Registries?

Multilayer Stent to Treat Type B Aortic Dissection with Splanchnic Compromise

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - Against: The TAVR Data are Only on High-Risk Patients with Limited Follow-Up

Motion: All Patients with Multivessel Disease and Impaired Left Ventricular Function Should Undergo Revascularization - Against: Revascularization Should be Reserved for Patient...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content